Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134069384> ?p ?o ?g. }
- W3134069384 endingPage "349" @default.
- W3134069384 startingPage "349" @default.
- W3134069384 abstract "Doxorubicin (DOX) is extensively applied in cancer therapy due to its efficacy in suppressing cancer progression and inducing apoptosis. After its discovery, this chemotherapeutic agent has been frequently used for cancer therapy, leading to chemoresistance. Due to dose-dependent toxicity, high concentrations of DOX cannot be administered to cancer patients. Therefore, experiments have been directed towards revealing underlying mechanisms responsible for DOX resistance and ameliorating its adverse effects. Nuclear factor erythroid 2-related factor 2 (Nrf2) signaling is activated to increase levels of reactive oxygen species (ROS) in cells to protect them against oxidative stress. It has been reported that Nrf2 activation is associated with drug resistance. In cells exposed to DOX, stimulation of Nrf2 signaling protects cells against cell death. Various upstream mediators regulate Nrf2 in DOX resistance. Strategies, both pharmacological and genetic interventions, have been applied for reversing DOX resistance. However, Nrf2 induction is of importance for alleviating side effects of DOX. Pharmacological agents with naturally occurring compounds as the most common have been used for inducing Nrf2 signaling in DOX amelioration. Furthermore, signaling networks in which Nrf2 is a key player for protection against DOX adverse effects have been revealed and are discussed in the current review." @default.
- W3134069384 created "2021-03-15" @default.
- W3134069384 creator A5002304555 @default.
- W3134069384 creator A5007646167 @default.
- W3134069384 creator A5009854635 @default.
- W3134069384 creator A5013368102 @default.
- W3134069384 creator A5026001143 @default.
- W3134069384 creator A5030742531 @default.
- W3134069384 creator A5032458020 @default.
- W3134069384 creator A5041093222 @default.
- W3134069384 creator A5058193427 @default.
- W3134069384 creator A5085120624 @default.
- W3134069384 creator A5090236421 @default.
- W3134069384 creator A5090838781 @default.
- W3134069384 date "2021-02-26" @default.
- W3134069384 modified "2023-10-05" @default.
- W3134069384 title "Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery" @default.
- W3134069384 cites W1508323668 @default.
- W3134069384 cites W1650319068 @default.
- W3134069384 cites W1845929488 @default.
- W3134069384 cites W1866108613 @default.
- W3134069384 cites W1976792034 @default.
- W3134069384 cites W1977941840 @default.
- W3134069384 cites W1992608162 @default.
- W3134069384 cites W1996194206 @default.
- W3134069384 cites W1997163515 @default.
- W3134069384 cites W1999790277 @default.
- W3134069384 cites W2001986050 @default.
- W3134069384 cites W2004935845 @default.
- W3134069384 cites W2014603472 @default.
- W3134069384 cites W2016038200 @default.
- W3134069384 cites W2018328223 @default.
- W3134069384 cites W2023000155 @default.
- W3134069384 cites W2025330029 @default.
- W3134069384 cites W2025436220 @default.
- W3134069384 cites W2031215262 @default.
- W3134069384 cites W2033274952 @default.
- W3134069384 cites W2039346157 @default.
- W3134069384 cites W2041647205 @default.
- W3134069384 cites W2048310781 @default.
- W3134069384 cites W2059614540 @default.
- W3134069384 cites W2060647978 @default.
- W3134069384 cites W2062934426 @default.
- W3134069384 cites W2063397349 @default.
- W3134069384 cites W2064641041 @default.
- W3134069384 cites W2068878269 @default.
- W3134069384 cites W2079535840 @default.
- W3134069384 cites W2089506765 @default.
- W3134069384 cites W2090938411 @default.
- W3134069384 cites W2091945251 @default.
- W3134069384 cites W2095189765 @default.
- W3134069384 cites W2095782040 @default.
- W3134069384 cites W2105102961 @default.
- W3134069384 cites W2108417479 @default.
- W3134069384 cites W2112198271 @default.
- W3134069384 cites W2113192813 @default.
- W3134069384 cites W2114101650 @default.
- W3134069384 cites W2115338196 @default.
- W3134069384 cites W2118774187 @default.
- W3134069384 cites W2120084535 @default.
- W3134069384 cites W2122781473 @default.
- W3134069384 cites W2123203533 @default.
- W3134069384 cites W2126163147 @default.
- W3134069384 cites W2130240344 @default.
- W3134069384 cites W2131032222 @default.
- W3134069384 cites W2132057867 @default.
- W3134069384 cites W2132730335 @default.
- W3134069384 cites W2141087913 @default.
- W3134069384 cites W2141300701 @default.
- W3134069384 cites W2146472590 @default.
- W3134069384 cites W2146521396 @default.
- W3134069384 cites W2150448827 @default.
- W3134069384 cites W2155324869 @default.
- W3134069384 cites W2155498173 @default.
- W3134069384 cites W2157039258 @default.
- W3134069384 cites W2157647588 @default.
- W3134069384 cites W2161905207 @default.
- W3134069384 cites W2168903064 @default.
- W3134069384 cites W2246363423 @default.
- W3134069384 cites W2267696663 @default.
- W3134069384 cites W2336661473 @default.
- W3134069384 cites W2460811036 @default.
- W3134069384 cites W2515257966 @default.
- W3134069384 cites W2516847391 @default.
- W3134069384 cites W2529157745 @default.
- W3134069384 cites W2536203302 @default.
- W3134069384 cites W2536439557 @default.
- W3134069384 cites W2538437447 @default.
- W3134069384 cites W2564870138 @default.
- W3134069384 cites W2620289761 @default.
- W3134069384 cites W2738730689 @default.
- W3134069384 cites W2738993646 @default.
- W3134069384 cites W2752633538 @default.
- W3134069384 cites W2755337174 @default.
- W3134069384 cites W2766507915 @default.
- W3134069384 cites W2770922541 @default.
- W3134069384 cites W2772927056 @default.
- W3134069384 cites W2774551227 @default.